DMCC Speciality Chemicals Ltd Q4 FY2024 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/ntq9ju1e0jjb9mh8gf6elewh.pdf

Key Takeaways


The Quarter's Damage: Commodities vs Specialities

Goculdas: "The last year, particularly the last quarter, was quite difficult, especially from the commodity chemicals point of view. While the volumes were good, the profitability was almost zero or even negative at times."

The China Overhang

Goculdas: "The Chinese have been very aggressive in dumping chemicals. And they have in fact run their manufacturing plants at high capacity, but they haven't consumed that much of the chemicals, which means that there was much more for exports and that is where they try to crash prices and regain market share."

Recovery Signals & New Growth Vectors

Goculdas: "It's a question of when it happens and how fast the ramp up is."

Capital Allocation & Balance Sheet


New Product Engine & Margin Guardrails

Goculdas: "Our baseline is that if we are not going to be able to achieve that as a margin, then it's not worth spending R&D."

What Management Would Not Say


Guidance & Commitments

CommitmentSpecificsTimeline
Debt eliminationRepay all fixed-term debt, assuming no further CAPEX3 years
Debt-free targetBecome debt free, assuming no further CAPEXFY27 or FY28
Boron business scaleReach ~₹150 cr from current CAPEX scaleNo date (underway)
Automotive product rampRamp up volumes post successful commercial trialsNext few quarters
New product margin threshold30% margin required for R&D investment approvalOngoing
Capacity expansion trigger70%-80% utilization plus good visibility and market pull before further CAPEXOngoing discipline

Key Metrics

MetricQ4 FY24
Revenue₹320 cr – ₹330 cr (full year FY24)
Revenue (previous year)Close to ₹400 cr (FY23)
EBITDA margin (historical expectation)15% to 20%
Speciality chemicals capacity utilizationAbout 50%
Bulk chemicals capacity utilizationAbove 90%
Revenue mix (Speciality : Commodity)50:50
Long-term target revenue mixTwo-thirds Speciality, one-third Commodity
Boron business revenue shareAbout 20% of total sales (~₹60 cr)
Boron business revenue potentialAbout ₹150 cr from current scale of CAPEX
Total business revenue potential₹450 cr – ₹500 cr at current raw material costs
Agrochemicals revenue contribution10% to 12% of total business, mostly Speciality
Speciality chemicals margin20% and up
Commodity chemicals marginZero plus minus 5%
Target margin for new products30%
Debt repaymentAbout ₹2 cr every month
Fixed term debt elimination timeline3 years, assuming no further CAPEX
R&D costReduced from 1.91% to 1.09% (year-on-year)
Dahej site grid independenceMore than 90% independent, only about 10% power from GEB grid
Capacity utilization threshold for expansion70%–80%
Dedicated plant setup timeline3 years from day zero including environmental clearance
Existing product capacity expansion timelineLess than a year